Skip to main content

Table 1 Clinicopathological characteristic and univariate analysis of prognostic factors in the 38 study patients

From: Decision-making in postoperative chemotherapy for ovarian metastasis from colorectal cancer: a retrospective single-center study

  No. of patients (%) MST (months) P-value
Age    0.484
 <49 years 16 (42.1) 23.7  
 >50 years 22 (57.9) 27.2  
Menstrual status    0.061
 Pre-menopausal 10 (26.3) 57.4  
 Post-menopausal 28 (73.7) 26.6  
Symptoms    0.845
 Yes 19 (50.0) 27.2  
 No 19 (50.0) 26.2  
Location    0.247
 Proximal colon 12 (31.6) 21.1  
 Distal colon 19 (50.0) 28.4  
 Rectum 7 (18.4) 27.7  
Differentiation    0.962
 Well or moderate 31 (81.6) 27.2  
 Poor or mucinous 4 (10.5) 18.1  
Depth of invasion    0.377
 T2–3 12 (31.6) 47.8  
 T4 24 (63.2) 27.2  
Lymph node metastasis    0.358
 Positive 29 (76.3) 26.6  
 Negative 9 (23.7) 28.9  
Timing of metastasis    0.775
 Synchronous 9 (23.7) 27.8  
 Metachronous 29 (76.3) 27.2  
Tumor size    0.663
 <12.0 cm 15 (39.5) 28.9  
 >12.1 cm 23 (60.5) 26.6  
Side of metastasis    0.125
 Unilateral 24 (63.2) 28.4  
 Bilateral 14 (36.8) 23.7  
Peritoneal dissemination    0.040
 Yes 23 (60.5) 26.6  
 No 15 (39.5) 57.4  
Combined metastasis    0.0005
 Ovarian metastasis only 7 (18.4) Not reached  
 Other metastases 31 (81.6) 26.2  
Operation time    0.019
 <169 min 25 (65.8) 28.9  
 >170 min 13 (34.2) 16.5  
Complete resection    0.0004
 R0 8 (21.1) Not reached  
 R1/2 30 (78.9) 26.2  
  1. MST median survival time